SynthesisBMJ (Clinical research ed.)2014

Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis.

Andrea C Tricco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.